Healthy Extracts (HYEX) Gains from Investment Securities (2015 - 2022)
Healthy Extracts (HYEX) reported Gains from Investment Securities of -$2643.0 for Q1 2022, down 102.5% quarter-over-quarter from $105571.0 in Q3 2016.
Healthy Extracts (HYEX) Gains from Investment Securities (2015 - 2022) Analysis & Trends
Healthy Extracts has reported Gains from Investment Securities for 3 years, with the latest figure at -$2643.0 in Q1 2022.
- For the quarter ending Q1 2022, Gains from Investment Securities changed N/A year-over-year to -$2643.0; the trailing twelve-month figure through Dec 2022 stood at -$2643.0 (changed N/A YoY), and the FY2022 full-year result was -$2643.0, changed N/A from the prior year.
- Gains from Investment Securities for Q1 2022 stood at -$2643.0, down from $105571.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was -$2643.0 in Q1 2022, with the low at -$2643.0 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Healthy Extracts | - | - | 957,429.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -2,643.00 |
| Mar 31, 2022 | -2,643.00 |
| Sep 30, 2016 | 105,571.00 |
| Sep 30, 2016 | 105,571.00 |
| Mar 31, 2016 | 209,448.00 |
| Mar 31, 2016 | 209,448.00 |
| Dec 31, 2015 | 239,021.00 |
| Dec 31, 2015 | 239,021.00 |